/ 2 items

#DHR↓

Featured/ RGEN/ 08/19/2026 · 10:10 AM

Wells Fargo and Stifel Flag Beneficiaries of Moderna-Merck Cancer Vaccine Data

Wells Fargo and Stifel say Moderna and Merck's Phase 3 cancer vaccine data could benefit Repligen, Danaher, Thermo Fisher, and Maravai LifeSciences. TEM stock is also surging.

Featured/ MASI/ 02/17/2026 · 3:07 AM

Danaher to Acquire Masimo in $9.9 Billion Deal – Boosting Patient Monitoring Tech

Danaher Corporation announces a major $9.9 billion acquisition of Masimo, a leader in pulse oximetry and patient monitoring. The cash deal at $180 per share strengthens Danaher's diagnostics business and aims to improve patient care in hospitals.